Literature DB >> 8835866

Myocyte death in heart failure.

P Anversa1, J Kajstura, G Olivetti.   

Abstract

Decompensated eccentric ventricular hypertrophy characterizes the transition from compensated pressure or volume over-load hypertrophy to myocardial dysfunction and failure. Myocyte loss is the major etiologic factor of wall thinning and chamber dilation and may condition the progression of the cardiac myopathy. Myocyte death can occur by apoptosis or necrosis, but the activation of the suicide program of myocytes exceeds necrotic cell death in the pathologic heart of ischemic origin. Whether reactive fibrosis constitutes a primary event in the initiation of ventricular dysfunction or a secondary reaction to myocyte death is an important unanswered question.

Entities:  

Mesh:

Year:  1996        PMID: 8835866     DOI: 10.1097/00001573-199605000-00004

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  22 in total

Review 1.  Pathophysiology of heart failure: a look at the future.

Authors:  R M Delgado; J T Willerson
Journal:  Tex Heart Inst J       Date:  1999

2.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

Review 3.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

4.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

Authors:  P Paradis; N Dali-Youcef; F W Paradis; G Thibault; M Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

5.  Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization.

Authors:  Sumbul Fatma; Donald E Selby; Reetu D Singla; Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2010-07-28       Impact factor: 8.401

6.  Interrelations between oxidative stress and calcineurin in the attenuation of cardiac apoptosis by eugenol.

Authors:  Rashmi Choudhary; Kaushala Prasad Mishra; Chivukula Subramanyam
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

7.  Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

Authors:  Dinender K Singla; Reetu D Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

8.  Direct intracardiac injection of umbilical cord-derived stromal cells and umbilical cord blood-derived endothelial cells for the treatment of ischemic cardiomyopathy.

Authors:  Paula H Suss; Luiz Guilherme A Capriglione; Fabiane Barchiki; Lye Miyague; Danielle Jackowski; Letícia Fracaro; Andressa V Schittini; Alexandra C Senegaglia; Carmen L K Rebelatto; Márcia Olandoski; Alejandro Correa; Paulo R S Brofman
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-08

Review 9.  AT2 receptors targeting cardiac protection post-myocardial infarction.

Authors:  Elena Kaschina; Dilyara Lauer; Patrick Schmerler; Thomas Unger; U Muscha Steckelings
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

10.  Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression.

Authors:  Zuyi Yuan; Chiharu Kishimoto; Keisuke Shioji; Hajime Nakamura; Junji Yodoi; Shigekake Sasayama
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.